Option chain shows key data for GMO Payment Gateway's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for GMO Payment Gateway.

GMO Payment Gateway (OTC:GMYTF) Stock, Option Chain

GMO Payment Gateway Inc is a settlement service company. The company offers payment solutions for credit cards, convenience store settlements, catalogue and TV purchases, and online shopping and e-commerce. The service includes the processing of payments, the storage of sensitive personal data, and recurring billing options. GMO Payments Gateway operates in Japan.

News

Intraday Update

Markets

Movers

Trading Ideas

AAVMY

ARCH BIOPARTNERS INC ORD by Arch Biopartners Inc.

ACHFF

ACRX

ADMG

ANGO

AOXY

ASPCF

ATRO

ATROB

AWLCF

BIOIF

BLUBF

BMMJ

BNFT

BORR

BSBR

BSET

BUDFF

CDEV

CEIX

CJPRY

CNNB

CPNFF

CRWG

CTRM

CULP

CVGI

CYBQY

DKAM

DKGR

DLRYF

DMCHY

DYLLF

ECOL

EJPRY

EMLL

ENBL

ETCC

ETFM

GEIN

GFGSF

GLYE

GNMK

GTCH

HAIPF

HNRG

IMAC

INND

ITEX

JAMN

JAPSY

KEQU

KNCAF

KOTMY

LATF

LIVE

LNTH

LONE

LPRRF

LQDT

MAHLY

MHVYF

MLMZF

MSPC

METALLIS RESOURCES INC by Metallis Resources, Inc.

MTLFF

MZDAF

NAKD

NBLX

NINOY

NMCI

NSANF

NSANY

NTGR

NZRFF

OMVKY

Stocks That Hit 52-Week Lows On Tuesday

GMO PAYMENT GATEWAY INC by GMO Payment Gateway, Inc.

GMO Payment Gateway Inc

The GEO Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) shares are trading lower after the company reported&nbsp;fourth-quarter revenue of&nbsp;$607.7&nbsp;million, beating <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b44000823/the-geo-group-reports-fourth-quarter-and-full-year-2024-results" rel="noreferrer noopener">the&nbsp;consensus of&nbsp;$607.44 million</a>.
Adjusted EBITDA declined to&nbsp;$108.0&nbsp;million from&nbsp;$129.0&nbsp;million a year ago quarter. Adjusted EPS&nbsp;of&nbsp;13 cents came below&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">the consensus of&nbsp;22 cents</a>.
Revenue for the fourth quarter of 2024 rose sequentially compared to the third quarter. However, earnings and adjusted EBITDA fell short of the company&#8217;s guidance, largely due to the elevated general and administrative expenses incurred during the period.
The increase in general and administrative expenses was partly due to previously announced management team reorganization and additional professional fees associated with preparing for future growth initiatives and related operations in 2025.
George C. Zoley, Executive Chairman of GEO, said, &#8220;In 2024, we also incurred $9 million of our previously announced $70 million investment to strengthen our capabilities to deliver expanded detention capacity, secure transportation, and electronic monitoring services to U.S. Immigration and Customs Enforcement (&#8220;ICE&#8221;) and the federal government.&#8221;
The company&#8217;s total net debt was approximately&nbsp;$1.7 billion at the end of the&nbsp;fourth quarter 2024.
Outlook: Geo sees FY25&nbsp;outlook for EPS of&nbsp;$0.74–&nbsp;$0.88 (vs. the consensus estimate of&nbsp;$1.55), adjusted EBITDA of $460 million-$485 million and revenue of around $2.5 billion <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">(vs. consensus of $2.76 billion)</a>.
In 2025, the company expects to further reduce the total net debt by around $150 million to $175 million, bringing the total net debt to about $1.55 billion.
In a separate release, Geo disclosed that it secured a 15-year, fixed-price contract worth about $1 billion with U.S. Immigration and Customs Enforcement (ICE) to provide support services for a federal immigration processing center at its 1,000-bed <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b44000864/the-geo-group-awarded-15-year-contract-by-u-s-immigration-and-customs-enforcement-for-company-owne" rel="noreferrer noopener">Delaney Hall Facility in Newark, New Jersey</a>.
The new support services contract is expected to generate over $60 million in annual revenue for GEO in its first full year, with margins in line with GEO&#8217;s Secure Services facilities.
GEO plans to reactivate the facility in the&nbsp;second quarter&nbsp;of 2025, with revenue and earnings normalizing in the second half of the year.
Investors can gain exposure to the stock via&nbsp;Ballast Small/Mid Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGMT#NYSE">MGMT</a>) and Schwab Fundamental U.S. Small Company ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNDA#NYSE">FNDA</a>).
Price Action: GEO shares are down 4% at $24.75 premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/25/02/43483622/bukeles-big-house-el-salvador-offers-us-a-prison-deal-like-no-other-musk-says-great-idea" target="_blank" rel="noreferrer noopener">Bukele&#8217;s Big House: El Salvador Offers US A Prison Deal Like No Other, Musk Says &#8216;Great Idea&#8217;</a></li>
</ul>

Earnings

Equities

Mid Cap

Guidance

FNDA

MGMT

GEO Q4 Earnings: Sales Beat, EPS Miss, New Immigration Contract And More

WIIM

TSAT

Telesat shares are trading higher after the company announced a  partnership with Intellian for Ka-Band flat panel user terminals.

Applovin shares are trading higher. The stock may be moving up after the company CEO released a note addressing the short seller reports.

Barrington Research analyst Kevin Steinke maintains Huron Consulting Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HURN#NASDAQ">HURN</a>) with a Outperform and raises the price target from $142 to $167.

Price Target

Analyst Ratings

HURN

Barrington Research Maintains Outperform on Huron Consulting Gr, Raises Price Target to $167

Piper Sandler analyst Joseph Catanzaro maintains Schrodinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDGR#NASDAQ">SDGR</a>) with a Overweight and lowers the price target from $50 to $45.

SDGR

Piper Sandler Maintains Overweight on Schrodinger, Lowers Price Target to $45

Laird Superfood shares are trading lower after the company reported worse-than-expected Q4 sales results.

Piper Sandler analyst David Amsellem maintains Corcept Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>) with a Overweight and raises the price target from $67 to $78.

CORT

Piper Sandler Maintains Overweight on Corcept Therapeutics, Raises Price Target to $78

SNPS

Synopsys shares are trading higher. The company reported Q1 financial results, and multiple firms maintained Buy ratings on the stock.

Piper Sandler analyst Matt O'Brien maintains Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Overweight and raises the price target from $12 to $13.

ATEC

Piper Sandler Maintains Overweight on Alphatec Holdings, Raises Price Target to $13

LICN

Lichen China shares are trading lower after the company announced shares will trade on split-adjusted basis beginning on Mar. 3

Piper Sandler analyst Alex Goldfarb maintains Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) with a Overweight and lowers the price target from $90 to $75.

LINE

Piper Sandler Maintains Overweight on Lineage, Lowers Price Target to $75

QNRX

Quoin Pharmaceuticals shares are trading higher after the company announced its whole body data from ongoing pediatric netherton syndrome study.

Piper Sandler analyst Kashy Harrison maintains Itron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRI#NASDAQ">ITRI</a>) with a Neutral and raises the price target from $119 to $124.

ITRI

Piper Sandler Maintains Neutral on Itron, Raises Price Target to $124

ALBERT G. LOWENTHAL TRANSITIONS TO EXECUTIVE CHAIRMAN
ROBERT S. LOWENTHAL APPOINTED CEO &amp; PRESIDENT
NEW YORK, Feb. 27, 2025 /PRNewswire/ -- Oppenheimer Holdings Inc. today announced that Albert G. Lowenthal, Chairman of the Board of Directors and Chief Executive Officer (CEO), would step down as CEO of the Company and its primary operating subsidiary, Oppenheimer &amp; Co. Inc. (Opco), effective at the close of the Annual Shareholders Meeting of the Company to be held on May 5, 2025. Mr. Lowenthal will continue in his role as Chairman of the Company and also will serve as Executive Chairman of Opco. He will be succeeded by Robert S. Lowenthal, currently serving as President and Head of Investment Banking, who will become CEO and President.

Management

Oppenheimer Holdings Inc. Announces CEO Succession; Albert G. Lowenthal Transitions To Executive Chairman; Robert S. Lowenthal Appointed CEO & President

Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>, LUNRW))) ("Intuitive Machines") ("Company"), a leading space exploration, infrastructure, and services company, has announced its IM-2 mission Nova-C class lunar lander, Athena, launched on SpaceX's Falcon 9 rocket and successfully commissioned in space, marking the first time humanity has had three lunar landers en route to the Moon at the same time.
Athena established a stable attitude, solar charging, and radio communications contact with the Company's mission operations center in Houston after liftoff on February 26. The lander is in excellent health and preparing for a series of planned main engine firings to refine her trajectory ahead of lunar orbit insertion, which is planned for March 3. Intuitive Machines expects a lunar landing opportunity on March 6.

LUNR

Intuitive Machines' IM-2 Lunar Lander Successfully Commissioned And En Route To The Moon

HC Wainwright &amp; Co. analyst Kevin Dede reiterates MARA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) with a Buy and maintains $28 price target.

Reiteration

MARA

HC Wainwright & Co. Reiterates Buy on MARA Holdings, Maintains $28 Price Target

VMAR

Vision Marine Technologies shares are trading higher after the company announced a three-year exclusive deal with STERK for electric boats.

Contracts

BKTI

BK Technologies Receives A Purchase Order From A State Forestry Agency For Its InteropONE Solution, Terms Not Disclosed

Standard Motor Products (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMP#NYSE">SMP</a>) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.44 by 6.82 percent. This is a 27.03 percent increase over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $343.40 million which beat the analyst consensus estimate of $300.89 million by 14.13 percent. This is a 18.11 percent increase over sales of $290.76 million the same period last year.

Earnings Beats

Standard Motor Products Q4 2024 Adj EPS $0.47 Beats $0.44 Estimate, Sales $343.40M Beat $300.89M Estimate

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion disease
FDA meeting expected in Q2 2025 on the statistically significant results of the Phase 3 <a href="https://clinicaltrials.gov/study/NCT04538625">OnTarget</a> trial of crofelemer in the prespecified subgroup of patients with breast cancer
Jaguar has received an indication of interest to acquire the Company
SAN FRANCISCO, CA / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / February 27, 2025 / <a href="https://pr.report/7peo">Jaguar Health, Inc.</a> <a href="https://pr.report/7pep">(NASDAQ:</a><a href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) ("Jaguar" or the "Company") today announced that its Board of Directors (the "Board") has adopted a limited duration stockholder rights plan (the "Rights Plan").

JAGX

Jaguar Health Adopts Limited Duration Stockholder Rights Plan To Ensure Stockholders Can Realize Long-Term Value; Jaguar Has Received An Indication Of Interest To Acquire The Company

GMO Payment Gateway

Comments

GMO Payment Gateway

GMO Payment Gateway (GMYTF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga